skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,214  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: subject: Ophthalmology remove subject: Retrospective Studies remove subject: Science & Technology remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Spectral domain optical coherence tomography classification of diabetic macular edema: a new proposal to clinical practice
Spectral domain optical coherence tomography classification of diabetic macular edema: a new proposal to clinical practice
Material Type:
Article 		Add to My Research

Spectral domain optical coherence tomography classification of diabetic macular edema: a new proposal to clinical practice

Graefe's archive for clinical and experimental ophthalmology, 2020-06, Vol.258 (6), p.1165-1172 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2020 ;Springer-Verlag GmbH Germany, part of Springer Nature 2020. ;ISSN: 0721-832X ;EISSN: 1435-702X ;DOI: 10.1007/s00417-020-04640-9 ;PMID: 32152718

Full text available

Citations Cited by
2
Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients
Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients
Material Type:
Article 		Add to My Research

Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients

Investigative ophthalmology & visual science, 2013-05, Vol.54 (5), p.3378-3384 [Peer Reviewed Journal]

ISSN: 1552-5783 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.12-11503 ;PMID: 23611988

Full text available

Citations Cited by
3
Classification of optical coherence tomography images using a capsule network
Classification of optical coherence tomography images using a capsule network
Material Type:
Article 		Add to My Research

Classification of optical coherence tomography images using a capsule network

BMC ophthalmology, 2020-03, Vol.20 (1), p.114-114, Article 114 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2415 ;EISSN: 1471-2415 ;DOI: 10.1186/s12886-020-01382-4 ;PMID: 32192460

Full text available

Citations Cited by
4
Quantifying Microvascular Density and Morphology in Diabetic Retinopathy Using Spectral-Domain Optical Coherence Tomography Angiography
Quantifying Microvascular Density and Morphology in Diabetic Retinopathy Using Spectral-Domain Optical Coherence Tomography Angiography
Material Type:
Article 		Add to My Research

Quantifying Microvascular Density and Morphology in Diabetic Retinopathy Using Spectral-Domain Optical Coherence Tomography Angiography

Investigative ophthalmology & visual science, 2016-07, Vol.57 (9), p.OCT362-OCT370 [Peer Reviewed Journal]

ISSN: 1552-5783 ;ISSN: 0146-0404 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.15-18904 ;PMID: 27409494

Full text available

Citations Cited by
5
Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients
Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients
Material Type:
Article 		Add to My Research

Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

American journal of ophthalmology, 2019-04, Vol.200, p.85-94 [Peer Reviewed Journal]

2019 Elsevier Inc. ;Copyright © 2019 Elsevier Inc. All rights reserved. ;2019. Elsevier Inc. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2018.12.019 ;PMID: 30660771

Full text available

Citations Cited by
6
Long-Term Visual Outcomes and Morphologic Biomarkers of Vision Loss in Eyes With Diabetic Macular Edema Treated With Anti-VEGF Therapy
Long-Term Visual Outcomes and Morphologic Biomarkers of Vision Loss in Eyes With Diabetic Macular Edema Treated With Anti-VEGF Therapy
Material Type:
Article 		Add to My Research

Long-Term Visual Outcomes and Morphologic Biomarkers of Vision Loss in Eyes With Diabetic Macular Edema Treated With Anti-VEGF Therapy

American journal of ophthalmology, 2022-03, Vol.235, p.80-89 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021. Elsevier Inc. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2021.09.002 ;PMID: 34509431

Full text available

Citations Cited by
7
Real-world management of treatment-naïve diabetic macular oedema in Japan: two-year visual outcomes with and without anti-VEGF therapy in the STREAT-DME study
Real-world management of treatment-naïve diabetic macular oedema in Japan: two-year visual outcomes with and without anti-VEGF therapy in the STREAT-DME study
Material Type:
Article 		Add to My Research

Real-world management of treatment-naïve diabetic macular oedema in Japan: two-year visual outcomes with and without anti-VEGF therapy in the STREAT-DME study

British journal of ophthalmology, 2020-09, Vol.104 (9), p.1209-1215 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2019-315199 ;PMID: 31784500

Full text available

Citations Cited by
8
Continuous glucose monitoring metrics following sub-Tenon’s injection of triamcinolone acetonide for diabetic macular edema
Continuous glucose monitoring metrics following sub-Tenon’s injection of triamcinolone acetonide for diabetic macular edema
Material Type:
Article 		Add to My Research

Continuous glucose monitoring metrics following sub-Tenon’s injection of triamcinolone acetonide for diabetic macular edema

Graefe's archive for clinical and experimental ophthalmology, 2024-02, Vol.262 (2), p.449-456 [Peer Reviewed Journal]

The Author(s) 2023 ;ISSN: 0721-832X ;EISSN: 1435-702X ;DOI: 10.1007/s00417-023-06275-y

Digital Resources/Online E-Resources

Citations Cited by
9
Intravitreal fluocinolone acetonide 0.19 mg (Iluvien®) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients
Intravitreal fluocinolone acetonide 0.19 mg (Iluvien®) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients
Material Type:
Article 		Add to My Research

Intravitreal fluocinolone acetonide 0.19 mg (Iluvien®) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients

Graefe's archive for clinical and experimental ophthalmology, 2022-05, Vol.260 (5), p.1633-1639 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. ;The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021. ;ISSN: 0721-832X ;EISSN: 1435-702X ;DOI: 10.1007/s00417-021-05504-6 ;PMID: 34851465

Full text available

Citations Cited by
10
Vitrectomy with ILM peeling in diabetic macular edema in one eye vs. intravitreal anti-VEGF injections in the second eye: a comparative study
Vitrectomy with ILM peeling in diabetic macular edema in one eye vs. intravitreal anti-VEGF injections in the second eye: a comparative study
Material Type:
Article 		Add to My Research

Vitrectomy with ILM peeling in diabetic macular edema in one eye vs. intravitreal anti-VEGF injections in the second eye: a comparative study

Graefe's archive for clinical and experimental ophthalmology, 2023, Vol.261 (1), p.67-76 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 ;2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. ;The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. ;ISSN: 0721-832X ;EISSN: 1435-702X ;DOI: 10.1007/s00417-022-05774-8 ;PMID: 35869998

Full text available

Citations Cited by
11
Hyperreflective foci in OCT image as a biomarker of poor prognosis in diabetic macular edema patients treating with Conbercept in China
Hyperreflective foci in OCT image as a biomarker of poor prognosis in diabetic macular edema patients treating with Conbercept in China
Material Type:
Article 		Add to My Research

Hyperreflective foci in OCT image as a biomarker of poor prognosis in diabetic macular edema patients treating with Conbercept in China

BMC ophthalmology, 2019-07, Vol.19 (1), p.157-157, Article 157 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;The Author(s). 2019 ;ISSN: 1471-2415 ;EISSN: 1471-2415 ;DOI: 10.1186/s12886-019-1168-0 ;PMID: 31337360

Full text available

Citations Cited by
12
Outcomes of Patients With Active Diabetic Macular Edema at the Time of Cataract Surgery Managed With Intravitreal Anti–Vascular Endothelial Growth Factor Injections
Outcomes of Patients With Active Diabetic Macular Edema at the Time of Cataract Surgery Managed With Intravitreal Anti–Vascular Endothelial Growth Factor Injections
Material Type:
Article 		Add to My Research

Outcomes of Patients With Active Diabetic Macular Edema at the Time of Cataract Surgery Managed With Intravitreal Anti–Vascular Endothelial Growth Factor Injections

American journal of ophthalmology, 2021-09, Vol.229, p.194-199 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021. Elsevier Inc. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2021.04.002 ;PMID: 33852907

Full text available

Citations Cited by
13
Prevalence of cystoid macular oedema, epiretinal membrane and cataract in retinitis pigmentosa
Prevalence of cystoid macular oedema, epiretinal membrane and cataract in retinitis pigmentosa
Material Type:
Article 		Add to My Research

Prevalence of cystoid macular oedema, epiretinal membrane and cataract in retinitis pigmentosa

British journal of ophthalmology, 2019-08, Vol.103 (8), p.1163-1166 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2018-311964 ;PMID: 30291136

Full text available

Citations Cited by
14
Efficacy and safety of single-dose dexamethasone implantation for patients with persistent diabetic macular edema: a systematic review and meta-analysis
Efficacy and safety of single-dose dexamethasone implantation for patients with persistent diabetic macular edema: a systematic review and meta-analysis
Material Type:
Article 		Add to My Research

Efficacy and safety of single-dose dexamethasone implantation for patients with persistent diabetic macular edema: a systematic review and meta-analysis

Graefe's archive for clinical and experimental ophthalmology, 2022-02, Vol.260 (2), p.405-413 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. ;The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021. ;ISSN: 0721-832X ;EISSN: 1435-702X ;DOI: 10.1007/s00417-021-05369-9 ;PMID: 34550419

Full text available

Citations Cited by
15
Changes in intraocular pressure after intravitreal fluocinolone acetonide (ILUVIEN): real-world experience in three European countries
Changes in intraocular pressure after intravitreal fluocinolone acetonide (ILUVIEN): real-world experience in three European countries
Material Type:
Article 		Add to My Research

Changes in intraocular pressure after intravitreal fluocinolone acetonide (ILUVIEN): real-world experience in three European countries

British journal of ophthalmology, 2019-08, Vol.103 (8), p.1072-1077 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2019 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2018-312284 ;PMID: 30242062

Full text available

Citations Cited by
16
Association Between Hyperreflective Dots on Spectral-Domain Optical Coherence Tomography in Macular Edema and Response to Treatment
Association Between Hyperreflective Dots on Spectral-Domain Optical Coherence Tomography in Macular Edema and Response to Treatment
Material Type:
Article 		Add to My Research

Association Between Hyperreflective Dots on Spectral-Domain Optical Coherence Tomography in Macular Edema and Response to Treatment

Investigative ophthalmology & visual science, 2017-11, Vol.58 (13), p.5958-5967 [Peer Reviewed Journal]

ISSN: 1552-5783 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.17-22725 ;PMID: 29183041

Full text available

Citations Cited by
17
Vision Outcomes Following Anti–Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice
Vision Outcomes Following Anti–Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice
Material Type:
Article 		Add to My Research

Vision Outcomes Following Anti–Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice

American journal of ophthalmology, 2018-07, Vol.191, p.83-91 [Peer Reviewed Journal]

2018 The Authors ;Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jul 2018 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2018.04.010 ;PMID: 29684329

Full text available

Citations Cited by
18
Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyes
Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyes
Material Type:
Article 		Add to My Research

Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyes

British journal of ophthalmology, 2021-12, Vol.105 (12), p.1696-1704 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2020-317337 ;PMID: 33055088

Full text available

Citations Cited by
19
Early-switch versus late-switch in patients with diabetic macular edema: a cost-effectiveness study
Early-switch versus late-switch in patients with diabetic macular edema: a cost-effectiveness study
Material Type:
Article 		Add to My Research

Early-switch versus late-switch in patients with diabetic macular edema: a cost-effectiveness study

Graefe's archive for clinical and experimental ophthalmology, 2023-04, Vol.261 (4), p.941-949 [Peer Reviewed Journal]

The Author(s) 2022 ;2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0721-832X ;EISSN: 1435-702X ;DOI: 10.1007/s00417-022-05892-3 ;PMID: 36370170

Full text available

Citations Cited by
20
Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Macular Edema Secondary to Vein Occlusion
Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Macular Edema Secondary to Vein Occlusion
Material Type:
Article 		Add to My Research

Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Macular Edema Secondary to Vein Occlusion

American journal of ophthalmology, 2017-10, Vol.182, p.160-167 [Peer Reviewed Journal]

2017 Elsevier Inc. ;Copyright © 2017 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Oct 1, 2017 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2017.08.005 ;PMID: 28837790

Full text available

Citations Cited by

Results 1 - 20 of 1,214  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (1,197)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1997  (13)
  2. 1997 To 2003  (47)
  3. 2004 To 2010  (199)
  4. 2011 To 2018  (494)
  5. After 2018  (462)
  6. More options open sub menu

Language 

  1. English  (1,192)
  2. Japanese  (157)
  3. French  (22)
  4. Portuguese  (11)
  5. Turkish  (3)
  6. German  (2)
  7. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait